Evaluating the potency of Sulawesi propolis compounds as ACE-2 inhibitors through molecular docking for COVID-19 drug discovery preliminary study

Evaluating the potency of Sulawesi propolis compounds as ACE-2 inhibitors through molecular docking for COVID-19 drug discovery preliminary study

Coronavirus disease (COVID-19) is a global pandemic caused by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2). Up to date, there has been no specific cure to treat the disease. Indonesia is one of the countries that is still fighting to control virus transmission. Yet, at the same time,...

Full description

Bibliographic Details
Main Authors: Apriliana Cahya Khayrani, Rafidha Irdiani, Reza Aditama, Diah Kartika Pratami, Kenny Lischer, Mohammad Javed Ansari, Arunachalam Chinnathambi, Sulaiman Ali Alharbi, Hesham S. Almoallim, Muhamad Sahlan
Format: Article
Language:English
Published: Elsevier 2021-03-01
Series:Journal of King Saud University: Science
Subjects:
COVID-19
Molecular docking
Potent inhibitor
ACE-2
Sulawesi propolis
Online Access:http://www.sciencedirect.com/science/article/pii/S1018364720304109

Internet

http://www.sciencedirect.com/science/article/pii/S1018364720304109

Similar Items